Market Access/ News/ News Novartis scores first approval for PIK3CA breast cancer drug George Underwood alpelisib, breast cancer, Novartis, PIK3CA, Piqray 0 Comment The FDA has approved Novartis’ breast cancer drug Piqray (alpelisib), making it the first marketed treatment targeting the Share X Novartis scores first approval for PIK3CA breast cancer drug https://pharmaphorum.com/news/novartis-scores-first-approval-for-pik3ca-breast-cancer-drug/
alpelisib, breast cancer, Novartis, PIK3CA, Piqray
0 Comment
